Search

Health, facial and vocal attributes and body height of men may affect a diverse range of social outcomes such as attractiveness to potential mates and competition for resources. Despite evidence that each parameter plays a role in mate choice, the relative role of each and inter-relationships between them, is still poorly understood. In this study, we tested relationships both between these parameters and with testosterone and immune function. We report positive relationships between testosterone with facial masculinity and attractiveness, and we found that facial masculinity predicted facial attractiveness and antibody response to a vaccine. Moreover, the relationship between antibody response to a hepatitis B vaccine and body height was found to be non-linear, with a positive relationship up to a height of 188 cm, but an inverse relationship in taller men. We found that vocal attractiveness was dependent upon vocal masculinity. The relationship between vocal attractiveness and body height was also non-linear, with a positive relationship of up to 178 cm, which then decreased in taller men. We did not find a significant relationship between body height and the fundamental frequency of vowel sounds provided by young men, while body height negatively correlated with the frequency of second formant. However, formant frequency was not associated with the strength of immune response. Our results demonstrate the potential of vaccination research to reveal costly traits that govern evolution of mate choice in humans and the importance of trade-offs among these traits. [ABSTRACT FROM AUTHOR]

The review starts off by outlining the history of the discovery of the male sex hormone testosterone and the historical background to the various, often dubious, approaches to the treatment of age-related endocrine disorders in older men. A discussion of congenital androgen deficiency in young men is followed by methods of diagnosing hypogonadism in older men. Among therapeutic options, the alternatives to direct testosterone replacement are discussed, although none of them have proved to be particularly successful in clinical practice. For testosterone replacement itself, various routes of administration and pharmaceutical formulations are now available, facilitating good monitoring and individualized therapy. [ABSTRACT FROM AUTHOR]